Pharmaceuticals Italy

Italy Psoriasis Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Italy Psoriasis Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Severity, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Italy · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $756.4 Mn Placeholder estimate
Estimate 2025 $804.8 Mn 2.3% of the global market
Projected 2034 $1.41 Bn 74.8% Adds $601.8 Mn over 9 forecast years
CAGR 2025–2034 6.4% Faster than 36% of 180 Pharmaceuticals markets here
Key players 6 +1
  • Italy is 2.34% of the global market.
  • In Europe, the largest is Germany at $1.21 Bn.
  • Fastest growing: Russia at 6.8% a year.
  • Italy ranks 3rd of 6 by size in Europe.

Market size projection

Italy

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$601.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Psoriasis Treatment Market market size by year, Italy
YearMarket sizeChange that yearSince 2025
2024 (estimate) $756.4 Mn — —
2025 (base) $804.8 Mn +$48.4 Mn —
2026 (forecast) $856.3 Mn +$51.5 Mn +6.4%
2027 (forecast) $911.1 Mn +$54.8 Mn +13.2%
2028 (forecast) $969.4 Mn +$58.3 Mn +20.5%
2029 (forecast) $1.03 Bn +$62.0 Mn +28.2%
2030 (forecast) $1.10 Bn +$66.0 Mn +36.4%
2031 (forecast) $1.17 Bn +$70.2 Mn +45.1%
2032 (forecast) $1.24 Bn +$74.7 Mn +54.4%
2033 (forecast) $1.32 Bn +$79.5 Mn +64.3%
2034 (forecast) $1.41 Bn +$84.6 Mn +74.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Italy Psoriasis Treatment Market Analysis at a glance
Market size, 2025$804.8 Mn placeholder estimate
Forecast, 2034$1.41 Bn placeholder estimate
Growth (CAGR), 2025–20346.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDrug class, severity and end user (see all)
Key playersJohnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, UCB and 1 more (see all)
Regulator in ItalyAIFASource: Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
Active clinical trials37 in ItalySource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Italy. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Italy Psoriasis Treatment Market Analysis Executive Summary

Psoriasis treatments clear red, scaly skin patches using creams, light therapy, pills and biologic injections.

Key segments of the psoriasis Treatment market include drug class (IL-17 Inhibitors, IL-23 Inhibitors and TNF Inhibitors) and severity (Mild and Moderate to Severe).

Bar chart: Italy Psoriasis Treatment market size, 2024–2034, placeholder estimates. $756.4 Mn in 2024, $804.8 Mn in 2025 and $1.41 Bn in 2034, 6.4% CAGR.
Italy Psoriasis Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Italy Psoriasis Treatment Market Dynamics

Market Growth Drivers

Rising interest in appearance, social media, more affordable treatments and new minimally invasive options are driving the psoriasis Treatment market. More clinics and chains are opening in fast-growing cities.

Opportunity

Treatments for men, at-home options, digital consultations and growth in Asia and the Middle East give the psoriasis Treatment market room to grow.

Market Restraints

Treatments are mostly paid out of pocket, results and safety vary between providers, and economic slowdowns can reduce spending on the psoriasis Treatment market.

Competitive Landscape for Psoriasis Treatment Market in Italy

The psoriasis Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Psoriasis Treatment Market in Italy

Psoriasis Treatment in Italy: rules, payment and research

Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by AIFA, the Italian Medicines Agency, which also negotiates prices and reimbursement.⁠[1] The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for.⁠[2] ClinicalTrials.gov lists 37 studies on Psoriasis Treatment that are recruiting, active or about to start in Italy.⁠[3]

[1] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.

[2] Italian Ministry of Health. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Italy. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for psoriasis Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Italy.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Psoriasis Treatment right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Psoriasis Treatment in context

Italy compared

  • Health spending per person: 3,398 US$ per person (2024). World: 1,317 US$ per person (2023). 4th highest of the 6 countries we cover in Europe.[1]
  • Doctors: 4.19 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 25.1% of people (2025). World: 10.4% of people (2025). Highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Psoriasis Treatment market in Italy?
Placeholder estimate: about $804.8 Mn in 2025, rising to about $1.41 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Psoriasis Treatment market in Italy growing?
Placeholder estimate: about 6.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Psoriasis Treatment market report cover?
The report splits the market by drug class (IL-17 Inhibitors, IL-23 Inhibitors, TNF Inhibitors, Oral Drugs and more), severity (Mild, Moderate to Severe) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Psoriasis Treatment market?
Key players include Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, UCB and Amgen Inc..
What is driving the Psoriasis Treatment market?
Rising interest in appearance, social media, more affordable treatments and new minimally invasive options are driving the psoriasis Treatment market. More clinics and chains are opening in fast-growing cities.
Who regulates Psoriasis Treatment in Italy?
Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by AIFA, the Italian Medicines Agency, which also negotiates prices and reimbursement. Source: Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
How is healthcare paid for in Italy?
The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for. Source: Italian Ministry of Health. Checked 14 Nov 2026.
How many clinical trials on Psoriasis Treatment are running in Italy?
37 studies are recruiting, active or about to start in Italy, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Italy. Retrieved 12 Nov 2026.
How much research is published on Psoriasis Treatment?
PubMed lists 926 papers on Psoriasis Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Italy

See all

Related on autoimmune diseases and skin and hair

See the topic